Facile discovery of red blood cell deformation and compromised membrane/skeleton assembly in Prader–Willi syndrome

Abstract

Prader–Willi syndrome (PWS) is a rare congenital disease with genetic alterations in chromosome 15. Although genetic disorders and DNA methylation abnormalities involved in PWS have been investigated to a significant degree, other anomalies such as those in erythrocytes may occur and these have not been clearly elucidated. In the present study, we uncovered slight anemia in children with PWS that was associated with increased red blood cell (RBC) distribution width (RDW) and contrarily reduced hematocrit (HCT) values. Intriguingly, the increased ratio in RDW to HCT allowed sufficient differentiation between the PWS patients from the healthy controls and, importantly, with individuals exhibiting conventional obesity. Further morphologic examinations revealed a significant deformity in erythrocytes and mild hemolysis in PWS patients. Comprehensive mechanistic investigations unveiled compromised membrane skeletal assembly and membrane lipid composition, and revealed a reduced F-actin/G-actin ratio in PWS patients. We ascribed these phenotypic changes in erythrocytes to the observed genetic defects, including DNA methylation abnormalities. Our collective data allowed us to uncover RBC deformation in children with PWS, and this may constitute an auxiliary indicator of PWS in early childhood.

Keywords

Prader–Willi syndrome / early diagnosis / erythrocyte deformation / membrane skeleton / membrane lipid

References

[1] Baldini L, Robert A, Charpentier B, Labialle S. Phylogenetic and molecular analyses identify SNORD116 targets involved in the Prader–Willi syndrome. Mol Biol Evol 2022; 39(1): msab348

[2] Butler MG, Miller JL, Forster JL. Prader–Willi syndrome—clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev 2019; 15(4): 207–244

[3] Ge MM, Gao YY, Wu BB, Yan K, Qin Q, Wang H, Zhou W, Yang L. Relationship between phenotype and genotype of 102 Chinese newborns with Prader–Willi syndrome. Mol Biol Rep 2019; 46(5): 4717–4724

[4] Juriaans AF, Kerkhof GF, Hokken-Koelega ACS. The spectrum of the Prader–Willi-like pheno- and genotype: a review of the literature. Endocr Rev 2022; 43(1): 1–18

[5] Tauber M, Hoybye C. Endocrine disorders in Prader–Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol 2021; 9(4): 235–246

[6] Yang-Li D, Fei-Hong L, Hui-Wen Z, Ming-Sheng M, Xiao-Ping L, Li L, Yi W, Qing Z, Yong-Hui J, Chao-Chun Z; PWS Cooperation Group of Rare Diseases Branch of Chinese Pediatric Society; Zhejiang Expert Group for PWS. Recommendations for the diagnosis and management of childhood Prader–Willi syndrome in China. Orphanet J Rare Dis 2022; 17(1): 221

[7] Pellikaan K, Rosenberg AGW, Kattentidt-Mouravieva AA, Kersseboom R, Bos-Roubos AG, Veen-Roelofs JMC, van Wieringen N, Hoekstra FME, van den Berg SAA, van der Lely AJ, de Graaff LCG. Missed diagnoses and health problems in adults with Prader–Willi syndrome: recommendations for screening and treatment. J Clin Endocrinol Metab 2020; 105(12): e4671–e4687

[8] Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood 2017; 130(16): 1795–1799

[9] Hedgeman E, Ulrichsen SP, Carter S, Kreher NC, Malobisky KP, Braun MM, Fryzek J, Olsen MS. Long-term health outcomes in patients with Prader–Willi syndrome: a nationwide cohort study in Denmark. Int J Obes 2017; 41(10): 1531–1538

[10] Bonkowsky JL, Son JH. Hypoxia and connectivity in the developing vertebrate nervous system. Dis Model Mech 2018; 11(12): dmm037127

[11] Lux SE 4th. Anatomy of the red cell membrane skeleton: unanswered questions. Blood 2016; 127(2): 187–199

[12] Solá E, Vayá A, Martínez M, Moscardó A, Corella D, Santaolaria ML, España F, Hernández-Mijares A. Erythrocyte membrane phosphatidylserine exposure in obesity. Obesity (Silver Spring) 2009; 17(2): 318–322

[13] Tang J, Yan Y, Li J, Yang B, Zhao X, Wan Y, Zheng JS, Mi J, Li D. Relationship between erythrocyte phospholipid fatty acid composition and obesity in children and adolescents. J Clin Lipidol 2019; 13(1): 70–79.e1

[14] Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood 2019; 133(1): 40–50

[15] Bunn HF. Erythropoietin. Cold Spring Harb Perspect Med 2013; 3(3): a011619

[16] Qu G, Wang X, Liu S. A crucial role of heme-regulated eIF2α kinase in maintaining cytoskeletal meshwork under an oxygen deficient condition. Sci Bull (Beijing) 2017; 62(15): 1045–1047

[17] Doherty GJ, McMahon HT. Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu Rev Biophys 2008; 37(1): 65–95

[18] Shohet SB, Ness PM. Hemolytic anemias. Failure of the red cell membrane. Med Clin North Am 1976; 60(5): 913–932

[19] Lu Y, Hanada T, Fujiwara Y, Nwankwo JO, Wieschhaus AJ, Hartwig J, Huang S, Han J, Chishti AH. Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia. Blood 2016; 128(1): 93–103

[20] Huang YS, Delgadillo LF, Cyr KH, Kingsley PD, An X, McGrath KE, Mohandas N, Conboy JG, Waugh RE, Wan J, Palis J. Circulating primitive erythroblasts establish a functional, protein 4.1R-dependent cytoskeletal network prior to enucleating. Sci Rep 2017; 7(1): 5164

[21] Stewart GW. Hemolytic disease due to membrane ion channel disorders. Curr Opin Hematol 2004; 11(4): 244–250

[22] Hao YH, Doyle JM, Ramanathan S, Gomez TS, Jia D, Xu M, Chen ZJ, Billadeau DD, Rosen MK, Potts PR. Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. Cell 2013; 152(5): 1051–1064

[23] Tacer KF, Potts PR. Cellular and disease functions of the Prader–Willi syndrome gene MAGEL2. Biochem J 2017; 474(13): 2177–2190

[24] Fountain MD, Oleson DS, Rech ME, Segebrecht L, Hunter JV, McCarthy JM, Lupo PJ, Holtgrewe M, Moran R, Rosenfeld JA, Isidor B, Le Caignec C, Saenz MS, Pedersen RC, Morgan TM, Pfotenhauer JP, Xia F, Bi W, Kang SL, Patel A, Krantz ID, Raible SE, Smith W, Cristian I, Torti E, Juusola J, Millan F, Wentzensen IM, Person RE, Küry S, Bézieau S, Uguen K, Férec C, Munnich A, van Haelst M, Lichtenbelt KD, van Gassen K, Hagelstrom T, Chawla A, Perry DL, Taft RJ, Jones M, Masser-Frye D, Dyment D, Venkateswaran S, Li C, Escobar LF, Horn D, Spillmann RC, Peña L, Wierzba J, Strom TM, Parenti I, Kaiser FJ, Ehmke N, Schaaf CP. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies. Genet Med 2019; 21(8): 1797–1807

[25] Sheetz MP, Sable JE, Döbereiner HG. Continuous membrane-cytoskeleton adhesion requires continuous accommodation to lipid and cytoskeleton dynamics. Annu Rev Biophys Biomol Struct 2006; 35(1): 417–434

[26] Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, Conrad M, Turker MZ, Gao M, Jiang X, Monette S, Pauliah M, Gonen M, Zanzonico P, Quinn T, Wiesner U, Bradbury MS, Overholtzer M. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nanotechnol 2016; 11(11): 977–985

[27] Pérez-Gordones MC, Lugo MR, Winkler M, Cervino V, Benaim G. Diacylglycerol regulates the plasma membrane calcium pump from human erythrocytes by direct interaction. Arch Biochem Biophys 2009; 489(1–2): 55–61

[28] Gupta P, Vijayan VK, Bansal SK. Sphingomyelin metabolism in erythrocyte membrane in asthma. J Asthma 2010; 47(9): 966–971

[29] Jauregibeitia I, Portune K, Rica I, Tueros I, Velasco O, Grau G, Trebolazabala N, Castaño L, Larocca AV, Ferreri C, Arranz S. Fatty acid profile of mature red blood cell membranes and dietary intake as a new approach to characterize children with overweight and obesity. Nutrients 2020; 12(11): 3446

[30] Grzelczyk A, Gendaszewska-Darmach E. Novel bioactive glycerol-based lysophospholipids: new data—new insight into their function. Biochimie 2013; 95(4): 667–679

RIGHTS & PERMISSIONS

Higher Education Press